← Back to Onesource Specialty Pharma Ltd. overview
Onesource Specialty Pharma Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹1,445 cr | ₹-18 cr | ₹-1.63 | ₹7,550 cr | ₹5,881 cr | -0.31% | 1.28% | 0.16x | -1.24% |
| FY2024 | ₹172 cr | ₹-391 cr | ₹-34.18 | ₹1,309 cr | ₹396 cr | -98.85% | -28.99% | 1.44x | -227.53% |
| FY2023 | ₹39 cr | ₹-800 cr | ₹-69.89 | ₹2,009 cr | ₹785 cr | -101.83% | -22.76% | 1.1x | -2,066.21% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.